加速康复外科理念下血液管理在腰椎结核围手术期的应用
Application of blood management in the perioperative period of lumbar tuberculosis under the concept of enhanced recovery after surgery
通信作者:
责任编辑: 孟莉
收稿日期: 2024-04-19 网络出版日期: 2024-09-06
| 基金资助: |
|
Corresponding authors:
Received: 2024-04-19 Online: 2024-09-06
| Fund supported: |
|
目的: 探索加速康复外科(ERAS)理念下腰椎结核围手术期的血液管理情况。方法: 采用回顾性研究方法,收集2020年5月至2023年5月河北省胸科医院经规范抗结核治疗后行单纯腰椎后路手术的61例腰椎结核患者资料,根据围手术期内不同的血液管理方式将患者分为ERAS血液管理组(观察组;32例)和常规血液管理组(对照组;29例)。比较两组患者手术时间、术中输血量、术后3d引流量、术后卧床时间和围手术期总失血量,记录术后并发症、血栓及刀口愈合情况,并使用疼痛视觉模拟评分(VAS)和Oswestry功能障碍指数(ODI)评估腰部疼痛及功能恢复情况。结果: 所有患者均顺利完成手术并获得随访。观察组手术时间[(127.65±25.37)min]、术中输血量[200(100,400)ml]、术后卧床时间[(5.09±1.15)d]、围手术期总出血量[833.30(678.76,897.22)ml]均明显低于对照组[(159.10±21.02)min、450(400,800)ml、(5.86±1.03)d、1086.37(793.60,1264.00)ml],差异均有统计学意义(t=5.240,P=0.000;Z=3.469,P=0.001;t=2.748, P=0.008;Z=3.134,P=0.002)。观察组和对照组患者术后共有5例发生皮疹、3例下肢血栓形成、8例因结核感染致刀口丙级愈合,发生率分别为9.38%(3/32)和6.89%(2/29)、6.25%(2/32)和3.45%(1/29)、15.63%(5/32)和10.34%(3/29),术后6个月的ODI评分分别为(7.38±1.07)%和(7.41±1.02)%,VAS评分分别为(2.81±0.74)分和(2.97±0.68)分,差异均无统计学意义(χ2=0.124,P=1.000;χ2=0.255,P=1.000; χ2=-0.593,P=0.553;t=0.145, P=0.885;t=0.843,P=0.403)。结论: ERAS指导下围手术期血液管理可明显降低手术时间、术后卧床时间和围手术期总失血量,有利于手术的顺利实施,降低手术失血风险,使患者尽快康复,有一定临床积极意义;但术后并发症、血栓形成、刀口愈合,以及腰部疼痛和功能恢复与常规血液管理方式并无差异,说明两种方式的术后并发症和远期疗效一致,安全性相同。
关键词:
Objective: To explore the blood management in the perioperative period of lumbar tuberculosis under the concept of enhanced recovery after surgery (ERAS). Methods: A retrospective study was conducted to collect the data of 61 patients with lumbar tuberculosis who underwent simple lumbar posterior surgery after standardized anti-tuberculosis treatment in Hebei Chest Hospital from May 2020 to May 2023. According to different blood management methods during the perioperative period, the patients were divided into ERAS blood management group (observation group; 32 cases) and conventional blood management group (control group; 29 cases). The operation time, intraoperative blood transfusion volume, postoperative 3-day drainage volume, postoperative bedridden time and total volume of perioperative blood loss were compared between two groups of patients. Lower back pain and functional recovery were assessed using the visual analogue scale (VAS) and Oswestry disability index (ODI). Results: All patients successfully completed the surgery and were followed up. The observation group showed lower operation time ((127.65±25.37) min), intraoperative blood transfusion volume (200 (100, 400) ml), postoperative bedridden time ((5.09±1.15) d), total perioperative blood loss volume (833.30 (678.76, 897.22) ml) compared to that of control group ((159.10±21.02) min, 450 (400, 800) ml, (5.86±1.03) d, 1086.37 (793.60, 1264.00) ml), and the differences were statistically significant (t=5.240, P=0.000; Z=3.469, P=0.001; t=2.748, P=0.008; Z=3.134, P=0.002). There were a total of 5 cases of rash complications, 3 cases of lower limbs thrombosis, and 8 cases of grade C healing due to tuberculosis infection in the two groups, with incidence rates of 9.38% (3/32) and 6.89% (2/29), 6.25% (2/32) and 3.45% (1/29), 15.63% (5/32) and 10.34% (3/29), respectively. The ODI scores at 6 months were (7.38±1.07) % and (7.41±1.02) %, and the VAS scores were (2.81±0.74) points and (2.97±0.68) points after 6 months of follow-up, respectively, with no significant differences (χ2=0.124, P=1.000; χ2=0.255, P=1.000; χ2=-0.593, P=0.553; t=0.145, P=0.885; t=0.843, P=0.403). Conclusion: Perioperative blood management directed by the concept of ERAS can significantly reduce surgery time, postoperative bedridden time and total perioperative blood loss, it is conducive to the smooth implementation of surgery, reduce the risk of surgical blood loss, and make the patient recover as soon as possible, which has a certain positive clinical significance. But is not better than common blood management for postoperative complications, thrombosis, surgical incision healing, lower back pain and functional recovery, indicates that the postoperative complications and long-term efficacy of the two methods are consistent and the safety is the same.
Keywords:
本文引用格式
刘树仁, 付琳, 王连波, 赵桂松, 李卓, 董昭良.
Liu Shuren, Fu Lin, Wang Lianbo, Zhao Guisong, Li Zhuo, Dong Zhaoliang.

开放科学(资源服务)标识码(OSID)的开放科学计划以二维码为入口,提供丰富的线上扩展功能,包括作者对论文背景的语音介绍、该研究的附加说明、与读者的交互问答、拓展学术圈等。读者“扫一扫”此二维码即可获得上述增值服务。
加速康复外科(enhanced recovery after surgery,ERAS)理念在脊柱结核外科的应用中已达成专家共识[1],并已在脊柱外科围手术期得到了广泛应用和推广[2]。但由于脊柱结核病灶清除术具有暴露范围大、清除病灶广、扩大减压等特点,极易出现手术时间长、出血量大、创伤大,甚至需要异体输血等情况,不仅增加住院费用,还会发生输血相关并发症(如过敏、溶血、发热等),延长患者住院时间和康复时间[3],使得脊柱结核围手术期血液管理成为临床亟需解决的问题。但该专家共识对脊柱结核围手术期血液管理的指导意见较少,也未能明确具体优化方案。因此,本研究通过探讨ERAS理念在脊柱结核围手术期血液管理中的应用,以为临床实施有效的围手术期血液管理提供参考。
资料和方法
一、研究对象
采用回顾性研究方法,选择2020年5月至2023年5月河北省胸科医院收治入院并接受腰椎结核后路病灶清除植骨融合内固定手术的166例患者,参照入组标准最终纳入61例患者作为研究对象。根据围手术期血液管理方式的不同将患者分为ERAS血液管理组(观察组)和常规血液管理组(对照组)。其中,观察组32例,包括男性17例、女性15例,年龄范围为27~82岁;腰2~3节段4例,腰3~4节段8例,腰4~5节段11例,腰5~骶1节段9例;椎管内脓肿9例,椎旁脓肿17例;合并非活动性肺结核7例。对照组29例,包括男性15例、女性14例,年龄范围为23~79岁;腰2~3节段5例,腰3~4节段6例,腰4~5节段9例,腰5~骶1节段9例;椎管内脓肿8例,椎旁脓肿17例;合并非活动性肺结核7例。两组患者在性别、年龄、病变节段、合并症、术前血红蛋白(Hb)、术前红细胞压积(Hct)等方面的差异均无统计学意义(P值均>0.05),见表1。
表1 不同临床特征在两组患者中的分布情况
| 临床特征 | 观察组(32例) | 对照组(29例) | 统计检验值 | P值 |
|---|---|---|---|---|
| 年龄(岁, | 58.61±21.79 | 58.22±20.23 | t=0.910 | 0.307 |
| 性别[例,构成比(%)] | χ2=0.012 | 0.913 | ||
| 男性 | 17(53.12) | 15(51.72) | ||
| 女性 | 15(46.88) | 14(48.28) | ||
| 病变部位[例,构成比(%)] | χ2=0.450 | 0.930 | ||
| 腰椎2~3 | 4(12.50) | 5(17.24) | ||
| 腰椎3~4 | 8(25.00) | 6(20.68) | ||
| 腰椎4~5 | 11(34.38) | 9(31.04) | ||
| 腰椎5~骶椎1 | 9(28.12) | 9(31.04) | ||
| 椎管内脓肿[例,发生率(%)] | 9(28.13) | 8(27.58) | χ2=0.002 | 0.963 |
| 椎旁脓肿[例,发生率(%)] | 17(53.13) | 17(58.62) | χ2=0.186 | 0.666 |
| 非活动性肺结核[例,发生率(%)] | 7(21.88) | 7(24.14) | χ2=0.044 | 0.834 |
| 术前血红蛋白(g/L, | 119.97±6.52 | 119.38±7.30 | t=0.331 | 0.740 |
| 术前红细胞压积(%, | 35.81±2.04 | 35.34±2.45 | t=0.805 | 0.404 |
纳入标准:(1)术后组织病理或结核分枝杆菌GeneXpert MTB/RIF 检测或分枝杆菌培养明确诊断为腰椎结核者;(2)术前均进行7~14d抗结核短程治疗;(3)血红蛋白均≥100g/L;(4)患者术前凝血功能基本正常;(5)均顺利完成手术;(6)随访时间至少10个月;(7)临床资料完整。
排除标准:(1)同时行多种术式或存在多节段脊柱结核者;(2)腰大肌脓肿较大不适合单纯后路手术者;(3)存在术前严重基础疾病或肿瘤病史者;(4)有输血及血液制品过敏史者。
二、研究方法
1.围手术期:是围绕手术的一个全过程,从患者决定接受手术治疗开始,到手术治疗完成直至基本康复,包含手术前、手术中及手术后的一段时间,具体指从确定手术治疗时起,直到与这次手术有关的治疗基本结束为止,时间约为术前5~7d至术后7~12d。
2.术前准备:患者术前常规完善腰椎DR、CT及MRI等影像检查,明确病变椎体节段及术中所用钉棒型号。并参考胸部CT及其他常规检查排除活动性肺结核。术前常规给予H-R-Z-E[异烟肼(H):0.3g/次, 1次/d;利福平(R):0.45g/次, 1次/d;吡嗪酰胺(Z):0.5g/次, 3次/d;乙胺丁醇(E):0.75g/次, 1次/d]抗结核治疗方案,用药时间为7~14d,待患者全身中毒症状改善后评估手术耐受情况,及早实施手术。
3.手术方法及处理策略:两组患者手术均由同一团队医师完成,均采用全身麻醉,均在术前30min预防性静脉点滴抗生素。具体手术操作如下:患者取俯卧位使腹部悬空,取正中切口,暴露相应椎体后置入椎弓根螺钉。选择椎体骨质破坏较多、脓肿较多的一侧或存在神经压迫症状明显的一侧作为病灶清除入路侧,切除该侧椎板、关节突关节,保留病椎椎弓根;建立良好的视野操作通道,将硬膜囊拉向内侧,创造足够的操作空间,寻找病变椎间盘使用尖刀十字切开后纵韧带,使用髓核钳将病变椎间盘摘除,用终板刮匙将脓液及死骨扩大刮除,使病灶彻底清除,并进行椎管内神经减压。将自体骨块剪成黄豆大小碎骨颗粒植入椎体前柱并夯实,完成植骨重建。椎弓根钉棒系统安装完毕后,两侧放置引流管,经C型臂X光机透视确认无误后逐层关闭刀口。术中将脓液及坏死物送分枝杆菌培养+药物敏感性试验(简称“药敏试验”)、普通菌培养+药敏试验、GeneXpert MTB/RIF及病理检查等。
4.术后处理:患者术后48h常规预防性应用抗生素治疗。术后当天开始自控式镇痛泵镇痛处理。术后3d开始使用低分子肝素抗凝治疗14d。术后1d开始在医生指导下进行双下肢气压泵治疗以预防血栓生成。继续应用抗结核药物,并根据实验室检查结果纠正低蛋白血症、电解质紊乱等并发症,给予必要的营养支持治疗。当负压引流管引流量<30ml时拔除引流管,嘱患者佩戴腰椎支具、适当下床锻炼活动。术后佩戴腰椎支具6~9个月,根据GeneXpert MTB/RIF及分枝杆菌培养+药敏试验结果及时调整抗结核药物治疗。一般抗结核治疗时间为12~18个月。
三、围手术期血液管理
1.常规血液管理:(1)合理应用单极电刀或双极电凝进行止血处理。(2)骨面渗血使用骨蜡,软组织渗血使用明胶海绵压迫止血。(3)放置引流管充分引流。(4)术后失血给予铁剂治疗。
2.ERAS血液管理:在常规血液管理的基础上,进行以下操作:(1)术中采用充气式加温装置维持体温[5]。(2)由麻醉师通过即时监测血气,根据患者心肺代偿功能及活动性出血情况,对血红蛋白在70~100g/L之间者进行限制性输血方案,血红蛋白>100g/L者不输血[6]。(3)通过麻醉技术及药物对出血较多部位进行控制性降压处理,将平均动脉压(mean arterial pressure,MAP)降至50~65mmHg(1mmHg=0.133kPa)或基线水平基础上降低 30%,从而达到减少术野出血的目的[7]。(4)切皮前15min静脉滴注1g氨甲环酸;进行病灶清除及减压时可局部应用氨甲环酸止血处理。(5)尽可能采用双极电凝进行局部止血,并应用止血材料对术中骨面和局部渗血进行压迫止血,但需避免造成椎管内神经压迫和异物反应。
四、观察指标及失血量计算
比较两组患者手术时间、术中输血量、术后3d引流量、术后卧床时间。评估术前及术后1d、3d血红蛋白和红细胞压积,计算围手术期总失血量。记录围手术输血并发症、术后血栓及刀口愈合情况等并发症。使用疼痛视觉模拟评分(visual analogue scale, VAS)和Oswestry 功能障碍指数(Oswestry disability index, ODI)评估术前及随访6个月腰部疼痛及功能恢复情况。其中,ODI由10个问题组成,每个问题有6个选项,每个选项为0~5分,分数越高表示功能障碍程度越重;得分累加后占总分(50分)的百分比即为ODI分值,得分越高说明患者功能障碍越严重。而VAS评分中,0分表示无痛,10分代表难以忍受的最剧烈疼痛。愈合程度分为甲级愈合(指愈合优良,没有不良反应的初期愈合)、乙级愈合(指愈合欠佳,愈合处有炎症反应,如红肿、硬结、血肿、积液等但未化脓)和丙级愈合(指切口化脓,需切开引流)。围手术期总失血量[8]采用Gross方程计算,公式为:围手术期实际失血量=理论失血量+输血量;理论失血量=总红细胞丢失量/术前Hct;总红细胞丢失量=术前血容量(patient blood volume,PBV)×(术前Hct-术后Hct),本研究使用术前及术后3d的红细胞压积计算理论失血量及实际失血量。PBV采用Nadler公式计算[9],即:血容量(L)男性=0.3669×身高3+0.03219×体质量+0.6041;血容量(L)女性=0.3561×身高3+0.03308×体质量+0.1833,身高和体质量单位分别为米(m)和千克(kg)。
五、统计学处理
采用SPSS 25.0软件进行数据的统计分析。符合正态分布的计量资料以“
结果
一、围手术期观测指标情况
表2 两组患者手术时间、术中输血量、引流量及术后卧床时间的比较
| 组别 | 手术时间 (min, | 术中输血量 [ml, M(Q1,Q3)] | 未输血患者 [例,占比(%)] | 术后3d总引流量 (ml, | 术后卧床时间 (d, |
|---|---|---|---|---|---|
| 观察组(32例) | 127.65±25.37 | 200(100,400) | 7(21.88) | 108.11±17.40 | 5.09±1.15 |
| 对照组(29例) | 159.10±21.02 | 450(400,800) | 4(13.79) | 98.22±12.89 | 5.86±1.03 |
| 统计检验值 | t=5.240 | Z=3.469 | χ2=0.672 | t=1.573 | t=2.748 |
| P值 | 0.000 | 0.001 | 0.412 | 0.370 | 0.008 |
表3 两组患者总失血量的比较
| 组别 | 血红蛋白(g/L, | 红细胞压积(%, | 理论失血量 [ml,M(Q1,Q3)] | 实际失血量 [ml,M(Q1,Q3)] | ||
|---|---|---|---|---|---|---|
| 术后1d | 术后3d | 术后1d | 术后3d | |||
| 观察组(32例) | 107.84±6.15 | 102.42±6.51 | 31.28±1.92 | 29.53±2.06 | 522.03 (445.75,655.19) | 833.30 (678.76,897.22) |
| 对照组(29例) | 108.86±4.99 | 103.18±4.96 | 31.03±2.32 | 29.24±2.44 | 493.82 (451.20,624.00) | 1086.37 (793.60,1264.00) |
| 统计检验值 | t=0.705 | t=0.512 | t=0.454 | t=0.498 | Z=0.563 | Z=3.134 |
| P值 | 0.484 | 0.611 | 0.652 | 0.621 | 0.573 | 0.002 |
二、手术并发症
两组患者术后并发症、血栓形成及刀口愈合情况的差异均无统计学意义(P值均>0.05),见表4。输血后有5例患者出现皮疹,经糖皮质激素抗过敏治疗后减退,围手术期内未再出现。所有患者均未出现肺栓塞、脑梗死等情况,术后1个月发现3例患者出现下肢血栓,其中,观察组2例(小腿肌间静脉血栓1例和股静脉附壁血栓1例),对照组1例(小腿肌间静脉血栓)。小腿肌间静脉血栓患者口服利伐沙班10mg(1次/d)抗凝治疗2个月后复查血栓消失,股静脉附壁血栓患者收入血管外科放置滤器和溶栓治疗后继续口服利伐沙班10mg(1次/d)抗凝治疗2个月复查血栓消失,取出滤器。两组患者术后出现乙级愈合13例,未做处理,继续应用抗结核药物,血肿或积液自行吸收;刀口及引流管处结核感染8例(均为丙级愈合),其中,观察组5例,对照组3例,给予刀口及引流管口搔刮换药处理后愈合。
表4 两组患者术后并发症、血栓形成及刀口愈合情况
| 组别 | 并发症 [例,发生率(%)] | 血栓形成 [例,发生率(%)] | 刀口愈合情况[例,发生率(%)] | ||
|---|---|---|---|---|---|
| 甲级 | 乙级 | 丙级 | |||
| 观察组(32例) | 3(9.38) | 2(6.25) | 20(62.50) | 7(21.88) | 5(15.63) |
| 对照组(29例) | 2(6.89) | 1(3.45) | 20(68.97) | 6(20.69) | 3(10.34) |
| χ2值 | 0.124 | 0.255 | -0.593 | ||
| P值 | 1.000 | 1.000 | 0.553 | ||
三、术后腰椎疼痛及功能恢复评分
所有患者均获得随访,观察组术前和随访6个月的ODI、VAS评分均较对照组无明显变化,差异均无统计学意义(P值均>0.05);两组患者随访6个月的ODI和VAS评分均较术前明显降低,差异均有统计学意义(P值均<0.05),说明腰痛及功能恢复均较术前明显改善,见表5。
表5 两组患者术前及随访6个月的ODI及VAS评分情况
| 组别 | ODI评分(%, | VAS评分(分, | ||||||
|---|---|---|---|---|---|---|---|---|
| 术前 | 随访6个月 | t值 | P值 | 术前 | 随访6个月 | t值 | P值 | |
| 观察组(32例) | 65.13±2.47 | 7.38±1.07 | 110.287 | 0.000 | 7.97±0.78 | 2.81±0.74 | 28.611 | 0.000 |
| 对照组(29例) | 64.89±5.43 | 7.41±1.02 | 54.991 | 0.000 | 7.86±0.83 | 2.97±0.68 | 26.050 | 0.000 |
| t值 | 0.215 | 0.145 | 0.514 | 0.843 | ||||
| P值 | 0.836 | 0.885 | 0.609 | 0.403 | ||||
注 ODI评分:Oswestry 功能障碍指数;VAS评分:疼痛视觉模拟评分
讨论
一、腰椎结核围手术期血液管理
术前血液管理包括出凝血风险和贫血评估及治疗。患者凝血功能、血红蛋白水平、是否合并心脑血管疾病等均需术前谨慎评估。由于老年患者合并心脑血管疾病、服用抗凝药物较多,故应关注老年脊柱患者外科手术前的凝血风险和贫血评估。国内外专家共识均建议在术前停用治疗性抗凝药物,并应复查国际标准化比值(international normalized ratio,INR)以评估出血风险和凝血风险[10]。
术中血液管理包括体温调节、止血药物应用、控制性降压、限制性输血、止血方式等,这也是本研究中两组患者围手术期不同的血液管理方式所在。相较于传统血液管理方式,本研究观察组首先在切皮前15min静脉滴注了1g氨甲环酸,也在进行病灶清除及减压时局部应用了氨甲环酸。氨甲环酸作为一种抗纤溶活性物质,有明显止血、避免静脉血栓形成及肾损伤等并发症的功能,局部应用也可减少隐性失血量,但氨甲环酸的使用需要在明确无硬脊膜损伤情况下限制性使用,否则会发生严重神经毒性作用[11];另外,本研究观察组患者在手术创面的局部还应用了凝血酶冻干粉,既可以减少出血,还不会增加并发症的发生风险[12]。其次,观察组在术中采用了不同于对照组的充气式加温装置持续保持体温,有助于保护血小板及凝血酶的活性,从而降低围手术期出血风险[5]。再次,观察组在术中还使用了控制性降压的方式以达到减少术野出血的目的[7],这可能与控制性降压可以减少术中出血量、提供良好术野、缩短手术时间,并在停止降压后血压可逐渐恢复至术前正常水平,更不会永久性损伤器官[13]有关,这与本研究观察组的手术时间较对照组明显减少的结果一致。但值得注意的是,当患者术前有严重内科疾病及血栓病史时需要谨慎实施,可在神经电生理监测保护下进行,以避免降压后脊髓供血不足而使功能受损。另外,术中限制性输血策略可以降低脊柱手术围手术期的输血量,但不会影响患者术后康复[14],本研究观察组由麻醉师通过即时监测血气,根据患者心肺代偿功能及活动性出血情况进行限制性输血方案的实施,这可能是观察组输血量较对照组明显减少且理论失血量无变化的原因。最后,观察组多采用双极电凝进行局部止血,该方法效果确切、止血范围小、精度高,可减少手术失血量,缩短手术时间[15];并应用止血材料对术中骨面渗血和局部渗血进行压迫止血,优于对照组的骨蜡或明胶海绵压迫止血,但需避免造成椎管内神经压迫和异物反应[16]。
术后血液管理主要是出血防治和贫血纠正。术后术区持续出血和引流不畅均是引发硬膜外血肿的主要原因[17]。主要表现为切口周围疼痛和神经支配区域疼痛,严重者导致脊髓或神经根受压,出现大小便失禁、运动和感觉丧失,需要及时治疗处理。而对于术后出现贫血的患者,临床中口服铁剂最为稳妥,但如果血红蛋白<70g/L,则需要及时查找原因并进行输血治疗。本研究两组患者均未出现术后术区持续出血、引流不畅和贫血患者。
综上,观察组采用ERAS理念对腰椎结核围手术期进行全程的血液管理,采用物理及药物止血和控制性降压等方式减少了术中出血量和输血量,提高了术野清晰度,缩短了手术时间,减少了手术暴露时间,有利于手术的顺利实施和降低患者手术风险。
二、腰椎结核围手术期实际失血量
脊柱结核患者术后会出现红细胞压积及血红蛋白的明显下降,导致贫血,使伤口愈合、机体修复及自身功能状态的恢复较为缓慢,为患者平安度过围手术期埋下了不安全因素[18]。但由于结核病患者术中无法收集自体血回输,预估术中失血量并积极输血治疗是必要的。本研究观察组在 ERAS理念下进行围手术期血液管理,总失血量较对照组明显减少,而理论失血量两组无明显差异,认为实际失血量的差异主要由术中输血量减少而来,而且,总失血量的减少,也使患者术后康复更快,卧床时间更短。因术中吸引器血量、术野血量,以及手术衣、无菌巾、纱布血量主要依靠估测完成,存在较大的人为误差[19],故本研究未采用术中失血量数据。而理论失血量影响因素中隐性失血(主要是指毛细血管外渗在组织间隙或积聚在手术部位的失血[20])是一个重要因素。正如Smorgick等[21]在一项前瞻性研究中发现,脊柱后路减压融合手术患者隐性失血占总失血量的42%。因此,基于术中输血、血液稀释及浓缩等因素影响的复杂性,目前缺少对脊柱结核围手术期实际失血量研究的相关报道,本研究使用“实际失血量=理论失血量+输血量”的概念较准确地反映了患者围手术期的失血状态。
三、ERAS下血液管理的安全性
本研究两组患者术后均未出现肺栓塞和脑梗死等情况,术后1个月发现观察组有2例、对照组有1例出现下肢血栓,发生率无明显差异,均在口服利伐沙班抗凝治疗2个月后消失,说明两组血液管理方式均未增加术后发生血栓的风险。同时,控制术野结核感染扩散及刀口处的结核感染扩散与延迟愈合也是术者必须面对的问题,根据术后每例患者的病情、合并症及耐药结核病发生情况制定个体化足量足程的抗结核化疗方案是保证刀口及结核病灶愈合的关键。本研究观察组5例、对照组3例发生了刀口及引流管处的结核感染,均在给予刀口及引流管口搔刮换药处理后愈合;另外,观察组随访6个月的ODI和VAS评分也均与对照组差异无统计学意义,这些均说明血液管理方式的不同并未对术后并发症及预后产生明显影响,ERAS血液管理的安全性并不劣于传统血液管理方式。
综上所述,ERAS指导围手术期血液管理可明显降低手术时间、术中输血量、术后卧床时间和围手术期总失血量,但术后并发症、血栓形成、刀口愈合,以及腰部疼痛及功能恢复情况并没有明显优于传统血液管理方式,说明ERAS指导下的血液管理有利于手术的顺利实施、降低手术失血风险,使患者尽快康复,有一定临床积极意义;且不会影响患者术后并发症和远期疗效,具有与传统管理方法一致的安全性。但因本研究为单中心小样本研究,还需进一步扩大样本量随访观察。
利益冲突 所有作者均声明不存在利益冲突
作者贡献 刘树仁:制定并实施方案、论文撰写;付琳:协助制定方案、患者管理及随访;王连波和赵桂松:数据分析、文献查询、影像学资料评估;李卓和董昭良:协助方案制定、指导论文撰写和修改
参考文献
加速康复外科理念在脊柱结核外科中应用的专家共识
中国脊柱手术加速康复——围手术期管理策略专家共识
中国脊柱结核外科治疗指南(2022年版)
脊柱大手术围手术期血液管理专家共识
Blood-loss Management in Spine Surgery
Substantial blood loss during spine surgery can result in increased patient morbidity and mortality. Proper preoperative planning and communication with the patient, anesthesia team, and operating room staff can lessen perioperative blood loss. Advances in intraoperative antifibrinolytic agents and modified anesthesia techniques have shown promising results in safely reducing blood loss. The surgeon's attention to intraoperative hemostasis and the concurrent use of local hemostatic agents also can lessen intraoperative bleeding. Conversely, the use of intraoperative blood salvage has come into question, both for its potential inability to reduce the need for allogeneic transfusions as well as its cost-effectiveness. Allogeneic blood transfusion is associated with elevated risks, including surgical site infection. Thus, desirable transfusion thresholds should remain restrictive.
Reduction of Mean Arterial Pressure at Incision Reduces Operative Blood Loss in Adolescent Idiopathic Scoliosis
Spinal fusion surgery for adolescent idiopathic scoliosis (AIS) has been associated with significant blood loss and transfusion requirements. Reduction of mean arterial pressure (MAP) has benefits, but has been debated. This study aimed to analyze hypotensive anesthesia (MAP less than 65 mm Hg) at incision for its effect on blood loss.Retrospective analysis of 327 AIS patients treated by a single surgeon from 2000 to 2008. We recorded demographic, laboratory, and radiographic measurements and perioperative data, including complications. We estimated MAP from the anesthesia flow sheet at incision (I-MAP) and during the entire surgery (Avg MAP). Patients were stratified into 3 groups: low (MAP less than 65), medium (MAP 65-75), or high (MAP greater than 75). We also evaluated the effect of elevated blood pressure at incision. The groups were as follows: reduced (I-MAP less than Avg MAP), stable (I-MAP = Avg MAP), or elevated (I-MAP greater than Avg MAP). We performed comparisons using analysis of variance with Tukey's Multiple Comparison Test. Blood loss was recorded as absolute volume and percent total blood volume (%EBV).Of the 327 patients (mean age, 15 years; range, 10-21 years; 248 females), 129 received blood transfusions (29% allogenic). There was a reduction in blood loss comparing low (584 mL; 14% EBV) versus high I-MAP (871 mL; 20.3% EBV) (p =.03). Likewise, an elevated blood pressure at incision led to increased blood loss: reduced, 510 mL, 11.5% EBV; stable, 735 mL, 17.6% EBV; and elevated, 1,033 mL, 24.9% EBV (p =.000-.02). Operative time was decreased in the low group by up to 48 minutes (p =.002), as was blood loss per minute (2.6 mL/min vs. 3.8 mL/min). There were no complications related to the use of hypotension.Induction of hypotensive anesthesia (MAP less than 65 mm Hg) at incision reduces operative blood loss by 33%. In addition, elevations in blood pressure at incision increase blood loss by 29%, and operative time by 29 minutes.Copyright © 2013 Scoliosis Research Society. Published by Elsevier Inc. All rights reserved.
Estimating allowable blood loss: corrected for dilution
Prediction of blood volume in normal human adults
脊柱外科围手术期出血防治专家共识
Topical use of tranexamic acid can effectively decrease hidden blood loss during posterior lumbar spinal fusion surgery: A retrospective study
脊柱结核病灶清除术中局部应用凝血酶冻干粉的疗效分析
控制性降压技术在骨科手术中的应用
Institution-Wide Blood Management Protocol Reduces Transfusion Rates Following Spine Surgery
Spine surgery is associated with significant intraoperative blood loss, often leading to transfusion. Patients who receive transfusions have an increased length of stay and risk of perioperative complications. To decrease the transfusion rate, we implemented an evidence-based institution-wide restrictive transfusion blood management guideline. The goal of this study is to describe the impact of this guideline on our spine surgery patients.We analyzed the incidence of transfusion following 3709 single-institution, inpatient spine procedures before and after implementation of a revised blood transfusion protocol. The baseline period (1742 patients) from January 2014 to March 2015 was compared to the study period (1967 patients) of April 2015 to July 2016. One patient was excluded because of incomplete medical records. The revised protocol included establishing a postoperative blood transfusion trigger at hemoglobin < 7g/dL, instituting a computerized provider order entry, and appointing a physician champion to monitor and report progress.Transfusion rate decreased from 16.2% to 9.7% from baseline to study period, respectively (< .001). The number of transfusions in patients with hemoglobin > 7g/dL decreased to 4.9% from 6.1% ( = .09). The rate of transfusions with a prior hemoglobin test increased from 42.0% to 59.1% (< .001). Length of stay was reduced from 3.67 to 3.46 days ( = .04), and postsurgical infection rate was reduced from 1.5% to 0.6% ( = .01). There was no significant difference in total hospital costs following protocol implementation.Implementation of a restrictive transfusion protocol through use of a computerized provider order entry and a physician champion to oversee clinician compliance led to a 40.1% reduction in blood transfusion following spine surgery. Behavior changes were visible with a 40.7% increase in hemoglobin documentation before transfusion, and patients benefited from a reduction in length of stay and postsurgical infection rate. Future study is encouraged to understand the long-term impact of this intervention and its role in hospital expenditure.
The efficacy of bipolar sealer on blood loss in spine surgery: a meta-analysis
The purpose of this meta-analysis of randomized controlled trials (RCTs) and non-RCTs was to gather data to evaluate the efficacy and safety of bipolar sealer versus standard electrocautery in the management of spinal disease.The electronic databases including Embase, PubMed and Cochrane library were searched to identify relevant studies published from the time of the establishment of these databases up to January 2017. The primary outcomes were total blood loss, requirement of transfusion (rate and amount), and operation time. The secondary outcomes were length of hospital stay and postoperative wound infection. Data analysis was conducted with RevMan 5.3 software.A total of five studies involving 500 patients (261 patients in the BS group and 239 in the control group) were included in the meta-analysis. The pooled results revealed that application of bipolar sealer could decrease the total blood loss in spine surgery [WMD = -467.49, 95% CI (685.47 to -249.51); p < 0.05; I = 91%]. Compared with standard electrocautery, bipolar sealer was associated with lower rates of need for transfusion [OR = 0.30, 95% CI (0.16-0.55), p < 0.05; I = 0%]. In addition, patients in the BS group were likely to receive less amount of blood transfusion compared with patients in the control group[WMD = -0.73, 95% CI (-1.37 to -0.09), p < 0.05; I = 76%]. The mean operative time was shorter in the BS groups compared with the control group [SMD = -0.36, 95% CI (-0.60 to -0.13), p < 0.05; I = 0%]. There was no significant difference in terms of length of hospital stay [WMD = -0.73, 95% CI (-1.96 to 0.51), p = 0.25; I = 67%] and postoperative wound infection [OR = 0.88, 95% CI (0.31-2.48), p = 0.81; I = 0.0%] between both groups.The available evidence suggests that bipolar sealer is superior to standard electrocautery with less blood loss, shorter operation time and less transfusion requirement. There is no significant difference between both groups regarding length of hospitalization and wound infection. Hence, bipolar sealer is recommended in spine surgery. Because of the limitation of our study, more well-designed RCTs with large sample are required to provide further evidence of safety and efficacy between bipolar sealer and standard electrocautery in the treatment of spinal disease.
腰椎后路手术后椎管内血肿形成的影响因素分析
Causes and preventive measures of symptomatic spinal epidural haematoma after spinal surgery
脊柱术后隐性失血量与脊柱手术方式相关性的初步探讨
An international consensus statement on the management of postoperative anaemia after major surgical procedures
Despite numerous guidelines on the management of anaemia in surgical patients, there is no pragmatic guidance for the diagnosis and management of anaemia and iron deficiency in the postoperative period. A number of experienced researchers and clinicians took part in a two-day expert workshop and developed the following consensus statement. After presentation of our own research data and local policies and procedures, appropriate relevant literature was reviewed and discussed. We developed a series of best-practice and evidence-based statements to advise on patient care with respect to anaemia and iron deficiency in the postoperative period. These statements include: a diagnostic approach to iron deficiency and anaemia in surgical patients; identification of patients appropriate for treatment; and advice on practical management and follow-up that is easy to implement. Available data allow the fulfilment of the requirements of Pillar 1 of Patient Blood Management. We urge national and international research funding bodies to take note of these recommendations, particularly in terms of funding large-scale prospective, randomised clinical trials that can most effectively address the important clinical questions and this clearly unmet medical need.© 2018 Association of Anaesthetists.
脊柱外科围手术期辅助止血方法的研究进展
Hidden blood loss during posterior spine fusion surgery
Posterior spine fusion is associated with significant intra- and postoperative blood losses. When referring to the total blood loss during spine surgery, the standard is to measure the intraoperative bleeding plus the postoperative drainage. This ignores the "hidden" blood loss that was found to be significant in other fields of surgery.The purpose of this study was to examine whether posterior spine fusion carries a substantial hidden blood loss.A prospective study.We prospectively studied 114 patients undergoing instrumented posterior spinal fusion at one center between January 2011 and April 2011.Total blood loss, visible blood loss, and hidden blood loss.For each patient, the hidden blood loss was calculated by deducting the observed perioperative blood loss from the calculated total blood loss based on the hematocrit changes. We compared the percentage of the hidden blood loss out of the total blood loss for primary versus revision posterior spine fusion.Primary decompression and posterior fusion patients had a mean total true loss of 1,439 mL. Their calculated hidden loss was 600 mL, 42% of the total loss. After revision posterior spinal fusion surgery, the mean total blood loss was 1,606 mL. The mean visible loss was 975 mL, and the mean hidden loss was 631 mL, 39% of the total loss. Thus, there was no statistical difference in the hidden blood loss between primary and revision posterior spinal fusion surgeries (p>.05). We did not find a significant difference in the percentage of the hidden blood loss between patients who underwent one, two, or three or more levels of surgery.After posterior spinal fusion, there may be a large amount of the hidden blood loss.Copyright © 2013 Elsevier Inc. All rights reserved.
/
| 〈 |
|
〉 |

京公网安备11010202007215号